Please select a location from the dropdown to view relevant share classes and investments. Your home market is currently
Don't see your home market? Change Edition

Best- and Worst-Performing Swiss Stocks of 2025

Galderma and Huber+Suhner rank among the best stocks in 2025, while the worst include Sonova and SIG Group.

illustration of a flag with chart icons and time series lines.

The Morningstar Switzerland Index rose 17.82% in 2025 amid a rally in the consumer cyclical sector. The Switzerland index tracks the performance of the top 97% of the Swiss investable universe by market cap, and each year we screen from among the stocks in this index to find the best- and worst-performing companies. Data in this article is sourced from Morningstar Direct.

The Best-Performing Swiss Stocks of 2025

  1. Huber+Suhner HUBN
  2. Montana Aerospace AERO
  3. Cosmo Pharmaceuticals COPN
  4. Jungfraubahnen Management JFN
  5. Galderma GALD

The Worst-Performing Swiss Stocks of 2025

  1. Lem Europe LEHN
  2. Tecan Trading TECN
  3. SIG Group SIGN
  4. Skan SKAN
  5. Sonova SOON

Metrics for the Best-Performing Swiss Stocks

Huber+Suhner HUBN

  • Sector: Technology
  • Industry: Communication Equipment
  • Economic Moat: Not Rated

Huber+Suhner fell 0.96% in December, however, shares were still up 100.91% for the past year. The company’s stock has a quantitative Morningstar Rating of 2 stars.

Montana Aerospace AERO

  • Sector: Industrials
  • Industry: Aerospace & Defense
  • Economic Moat: Not Rated

Montana Aerospace jumped 14.34% in December, leaving the stock up 97.63% for the past year. Shares were 13.32% below their last high on Nov. 3, 2025. The company’s stock has a quantitative Morningstar Rating of 2 stars.

Cosmo Pharmaceuticals COPN

  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Economic Moat: Not Rated

Cosmo Pharmaceuticals soared 69.13% in December, leaving the stock up 70.92% for the past year. The company’s stock has a quantitative Morningstar Rating of 3 stars.

Jungfraubahnen Management JFN

  • Sector: Industrials
  • Industry: Railroads
  • Economic Moat: Not Rated

Jungfraubahnen Management leapt 10.00% in December, leaving shares up 70.88% for the past year. Jungfraubahnen Management has a quantitative Morningstar Rating of 2 stars.

Galderma GALD

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Economic Moat: Narrow

Galderma rose 1.31% in December, leaving the stock up 61.33% for the past year. The company’s stock has a Morningstar Rating of 1 stars, trading at a 43% premium to its fair value estimate of CHF 113.00.

Metrics for the Worst-Performing Swiss Stocks

Lem Europe LEHN

  • Sector: Technology
  • Industry: Electronic Components
  • Economic Moat: Not Rated

Lem Europe fell 7.81% in December, leaving the stock down 60.19% for the past year. Shares were 68.95% lower than their last high on Feb. 14, 2025. The company’s stock has a quantitative Morningstar Rating of 3 stars.

Tecan Trading TECN

  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Economic Moat: Not Rated

Tecan Trading decreased 7.15% in December, leaving shares down 35.26% for the past year. Stocks in the company were 48.19% below the last high on Jan. 28, 2025. Tecan Trading has a quantitative Morningstar Rating of 3 stars.

SIG Group SIGN

  • Sector: Consumer Cyclical
  • Industry: Packaging & Containers
  • Economic Moat: Not Rated

SIG Group jumped 16.49% in December, but was still down 34.49% over the past year. Shares were 45.59% below their last high on Feb. 21, 2025. The company’s stock has a quantitative Morningstar Rating of 3 stars.

Skan SKAN

  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Economic Moat: Not Rated

Skan gained 7.21% in December, but over the past year, shares were down 30.30%. Stocks in the company were 34.73% below the last high on Jan. 22, 2025. Skan has a quantitative Morningstar Rating of 3 stars.

Sonova SOON

  • Sector: Healthcare
  • Industry: Medical Devices
  • Economic Moat: Narrow

Sonova rose 3.50% in December, but was still down 28.88% over the past year. Shares were 36.41% below their last high on Jan. 28, 2025. The company’s stock has a Morningstar Rating of 4 stars, trading at a 16% discount to its fair value estimate of CHF 247.00.

Companies that are not formally covered by a Morningstar analyst are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative star rating.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.